Stay updated on Immunotherapy Combo With Chemotherapy in Gastric Cancers Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combo With Chemotherapy in Gastric Cancers Clinical Trial page.

Latest updates to the Immunotherapy Combo With Chemotherapy in Gastric Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed information about a clinical trial for the investigational drug relatlimab and the addition of new drug names and a revised version number.SummaryDifference6%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 5, 2025.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to reflect the latest version as v2.14.3, with the last update date changed to March 25, 2025. The previous version v2.14.2 and its update date of February 5, 2025, have been removed.SummaryDifference0.2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check88 days agoChange DetectedThe webpage has been updated to reflect new data regarding the objective response rates and safety assessments for participants in a clinical trial, including changes to the duration of response and the number of participants with adverse events. Additionally, the last update date has been changed to February 5, 2025.SummaryDifference28%
Stay in the know with updates to Immunotherapy Combo With Chemotherapy in Gastric Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combo With Chemotherapy in Gastric Cancers Clinical Trial page.